Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: Rationale and design of the epidemiological studies within the IMI DIRECT Consortium

Diabetologia

Volumn 57, Issue 6, 2014, Pages 1132-1142

  Koivula, Robert W ^a   Heggie, Alison ^b   Barnett, Anna ^c   Cederberg, Henna ^d   Hansen, Tue H ^e   Koopman, Anitra D ^f   Ridderstråle, Martin ^g,h   Rutters, Femke ^f   Vestergaard, Henrik ^e   Gupta, Ramneek ⁱ   Herrgård, Sanna ⁱ   Heymans, Martijn W ^f   Perry, Mandy H ^j,k   Rauh, Simone ^f   Siloaho, Maritta ^d   Teare, Harriet J A ^l   Thorand, Barbara ^m,n   Bell, Jimmy ^o   Brunak, Søren ⁱ   Frost, Gary ^p   Jablonka, Bernd ^q   Mari, Andrea ^r   McDonald, Tim J ^j,k   Dekker, Jacqueline M ^f   Hansen, Torben ^e,s   Hattersley, Andrew ^t   Laakso, Markku ^d   Pedersen, Oluf ^e,u,v   Koivisto, Veikko ^w   Ruetten, Hartmut ^q   Walker, Mark ^b   Pearson, Ewan ^c   Franks, Paul W ^a,x,y   more..

^a LUND UNIVERSITY   (Sweden)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e Capital Region   (Denmark)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h STENO DIABETES CENTER   (Denmark)

ⁱ TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^j UNIVERSITY OF EXETER   (United Kingdom)

^k ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m INSTITUTE OF EPIDEMIOLOGY   (Germany)

ⁿ GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^o MEDICAL RESEARCH COUNCIL   (United Kingdom)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^r CNR   (Italy)

^s UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^t UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^u HAGEDORN RESEARCH INSTITUTE   (Denmark)

^v UNIVERSITY OF COPENHAGEN   (Denmark)

^w ELI LILLY AND COMPANY   (United States)

^x HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^y UMEÅ UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Epigenetic; Gene environment interaction; Genome; Glycaemic control; Lifestyle; Microbiome; Prediabetes; Proteome; Transcriptome; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ACCELEROMETRY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIET; DISEASE SEVERITY; FECES; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; INSULIN RELEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; METAGENOMICS; NAIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEOMICS; QUESTIONNAIRE; URINE; VENOUS BLOOD; BLOOD; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; EPIDEMIOLOGY; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PREGNANCY;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84901229328     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3216-x     Document Type: Article

References (28)

1. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
2. Ringborg A, Lindgren P, Yin DD, Martinell M, Stalhammar J (2010) Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes. Diabetes Metab 36:198-203
3. Mooy JM, Grootenhuis PA, de Vries H et al (1995) Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care 18:1270-1273
4. Rathmann W, Strassburger K, Heier M et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med J Br Diabet Assoc 26:1212-1219
5. Ajanki T (2013) ANDIS-Alla Nya Diabetiker i Skåne. http://diabetesportalen.se/foerdjupning/viktiga-vetenskapliga-undersoekningar/ andis-alla-nya-diabetiker-i-skaane/. Accessed 15 Oct 2013
6. Mennen LI, Balkau B, Vol S, Caces E, Eschwege E (1999) Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol 19:887-892
7. Doney AS, Fischer B, Leese G, Morris AD, Palmer CN (2004) Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler Thromb Vasc Biol 24:2403-2407
8. Groop L, Forsblom C, Lehtovirta M et al (1996) Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593
9. Vangipurapu J, Stancakova A, Kuulasmaa T et al (2012) Association between liver insulin resistance and cardiovascular risk factors. J Intern Med 272:402-408
10. Harder MN, Ribel-Madsen R, Justesen JM et al (2013) Type 2 diabetes risk alleles near BCAR1 and in ANK1 associate with decreased beta-cell function whereas risk alleles near ANKRD55 and GRB14 associate with decreased insulin sensitivity in the Danish Inter99 cohort. J Clin Endocrinol Metab 98:E801-E806
11. Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566-570
12. Berglund G, Elmstahl S, Janzon L, Larsson SA (1993) The Malmö Diet and Cancer Study. Design and feasibility. J Intern Med 233:45-51
13. Franks PW, Pearson E, Florez JC (2013) Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects. Diabetes Care 36:1413-1421
14. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548
15. Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221-S226
16. Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65
17. Thomas EL, Fitzpatrick JA, Malik SJ, Taylor-Robinson SD, Bell JD (2013) Whole body fat: content and distribution. Prog Nucl Magn Reson Spectrosc 73:56-80
18. Moshfegh AJ, Rhodes DG, Baer DJ et al (2008) The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr 88:324-332
19. Subar AF, Kipnis V, Troiano RP et al (2003) Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 158:1-13
20. Neuhouser ML, Tinker L, Shaw PA et al (2008) Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol 167:1247-1259
21. Wood DA, Kotseva K, Connolly S et al (2008) Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371:1999-2012
22. Black AE (2000) The sensitivity and specificity of the Goldberg cut-off for EI:BMR for identifying diet reports of poor validity. Eur J Clin Nutr 54:395-404
23. Black AE (2000) Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations. Int J Obes Relat Metab Disord 24:1119-1130
24. Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58:1212-1221
25. American Diabetes Association (2011) Standards of medical care in diabetes-2011. Diabetes Care 34(Suppl 1):S11-S61
26. Alssema M, Vistisen D, Heymans MW et al (2011) The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia 54:1004-1012
27. D'Orazio P, Burnett RW, Fogh-Andersen N et al (2006) Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med 44:1486-1490
28. Lakshmy R, Gupta R (2009) Measurement of glycated hemoglobin A1c from dried blood by turbidimetric immunoassay. J Diabetes Sci Technol 3:1203-1206